bindarit has been researched along with Acute Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JP; Ding, XL; Qiang, H; Wei, Q; Zhang, H; Zhang, HF; Zhou, GX; Zhu, XJ | 1 |
| Biondi, G; Ble, A; Bombardieri, S; Di Loreto, G; Guglielmotti, A; Mosca, M; Remuzzi, G; Ruggenenti, P | 1 |
| Bhatia, M; Chevali, L; Guglielmotti, A; Ramnath, RD | 1 |
1 trial(s) available for bindarit and Acute Disease
| Article | Year |
|---|---|
Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritis.
Topics: Acute Disease; Adult; Chemokine CCL2; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Indazoles; Kidney Diseases; Lupus Nephritis; Male; Middle Aged; Placebos; Propionates; Prospective Studies; Proteinuria; Remission Induction | 2011 |
2 other study(ies) available for bindarit and Acute Disease
| Article | Year |
|---|---|
Protective effects of MCP-1 inhibitor on a rat model of severe acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Chemokine CCL2; Immunohistochemistry; Indazoles; Male; Pancreas; Pancreatitis; Propionates; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2010 |
Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis.
Topics: Acute Disease; Animals; Ceruletide; Chemokine CCL2; Disease Models, Animal; Indazoles; Inflammation; Mice; Necrosis; Pancreas; Pancreatitis; Propionates | 2005 |